#pacg

[spaciebabie]

im online. reblogging posts. what about you

[nnn-lll-nnn]

CODAR-NAVAL-COSTL/PSC/OSCNC/RADAR

(1/10)

PacG: substantial.

Coherency SS: L/I line at 0030, U/S line is at 010-0, Jumbled, /break/ Non lossy packet burst transmission is as follows.

/Break/

+++-++-----------------+-----+-----------+-+-----

1001-1000-0010-0000-0011-1001-1100-0

1100-1000-1001-0110-0100-1001-1000-0

1111-1102-0300-1034-5598-1063-1111-0

6219-5221-0001-2361-7321-1192-9389-0

1158-9231-6172-3552-8711-8829-1200-0

1211-0007-7326-7171-7712-1777-8121-8785-0

6526-7217-5321-7772-1358-9219-6177-7236-0

-------------+-------------+---+++---------+-------

Standby for information.

[airmanisr]

F-PACG, Stampe SV-4C, AJBS La Ferte Alais, 28-08-2021 by Gordon Riley

[crimsonpublishers-medical]

Primary Angle Closure Glaucoma: A Review- Crimson Publishers

Primary Angle Closure Glaucoma: A Review- Crimson Publishers

Glaucoma is a leading cause of irreversible blindness worldwide. Primary angle closure glaucoma (PACG), is the second most common form of glaucoma and associated with the closure of the anterior chamber angle. Peripheral anterior synechia (PAS) frequently develop due to an attack of prolonged acute attack or a series subacute attack of angle closure glaucoma. These PAS are usually high and broad and very difficult to find out whether the PAS formed before or during the attack or possibly at both times. Principal management strategy for PACG is about anterior chamber angle by understanding the early stages of appositional angle closure before the PAS. In this review, we describe the current understanding regarding the pathophysiology and treatment of PACG.

For more open access journals in crimson publishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link: https://crimsonpublishers.com/rmes/

[otcsocialnetwork]

12/15/22 TRENDS

$PHIL $SBET $PCTL $SNPX $TTCM $CTM $ICVX $OG $TPL $INTU $ALGN $GSTC $ADHC $PQEFF $FNGD $EP $CGRA $MJLB $DBMM $VZ $HVCW $KBLB $TRKA $MTNB $NLST $REGN $SFLM $DPSI $NRGD $VTNR $AVXL $GETR $WTM $RNA $ARAT $SPY $BOMO $ADBE $OPTT $VXIT $SOXS $ENSV $NRGU $GAU $ARGX $ITRM $GVSI $NSAV $EPAM $CYDY $ALL $IBIO $BERZ $CLDX $SGML $NWBO $POOL $MMAT $GHC $LEN $TECS $CYBL $AAPL $NBLD $ARKK $AVCT $GDXD $DPLS $CRKN $PBLA $LPTV $BRLL $MELI $UATG $AMC $GLDG $TOMDF $LRCX $RGBP $NVAX $ENZC $POL $SCPS $ASML $RDGL $TGLO $GAME $ORGN $AMRN $ZIM $LWLG $AGSS $GDVM $COSM $CASI $COHN $AGYS $SFRX $HIRU $DVLP $BABA $VNTH $CPHI $RMHB $BKNG $RXMD $AABB $DSS $MULN $UNVC $APRN $RBLX $HMBL $QQQ $STRY $TETOF $ASTA $CMG $PACG $KAVL $SRZN $LCLP $DWAC $RICK $VLON $TSLA $EGOC $JOB $WISA $NFLX $CORZ $AITX $NVR $MMTLP $NDSN $BBIG $ELA $WEBS $APSI $MTD $SQQQ $CPOP $DS $SNPW $MDGL $THRD $MRNA $FNGU $NUWE $CRL Check out our Free Penny Stock Screener HERE. http://dlvr.it/SfQxWY

[amiriandfriends]

Amiri & Friends #44 - Transmogrification Central

Artist: @sheastandefer

One of the loot rewards in Wrath of the Righteous is a spell called Transmogrify. It is intended to allow a caster to weaken a powerful monster (usually a henchman or villain) by reducing its difficulty to defeat by your Arcane or Divine skill +1d6, so it is easier to combat for the win. Sometimes, you don’t have any other options, though.

With the prevalence of demons and undead in Wrath, Kyra got a little too reliant on her laser powers (recharging any spell or blessing for a powerful attack...but only against those creature types), and encountered a monster with no conventional means of fighting. Rather than take it on the chin, she used Transmogrify on the middling Cultist archer.

The trouble is, by the time you earn this loot spell, though, you are so powerful that casting it is a fairly ridiculous bonus, even against beefy villains. Against a standard monster, it was messy. Thanks to skill feats, mythic charges, and the Black Robes, Kyra’s Divine static bonus was already +12. After rolling max on d12 + d6, the Combat 14 archer had its difficulty reduced by 30. Needless to say, Kyra had no trouble then rolling her base strength to defeat it. 

[sirrogue]

Amiri and Friends #11 - Take Your Time

Artist: @sheastandefer

The downside of playing a melee fighter: small hand size and lots of weapons means not exploring very many times per turn. A few rounds and Seoni and Lem closed three locations between them (with help from the Academy text). Meanwhile, Amiri has been banging her head on one location, exploring once or twice a turn, still not closed...

(To be fair, it turned out the henchman was on the bottom of that location pile!)

[acdurston]

Heleen and I tried out the "don't call it 2nd edition" Pathfinder Adventure Card Game. Lots of fun. A very likely purchase. @officialpaizo @gen_con #pacg #gencon #gencon2019 (at Indiana Convention Center) https://www.instagram.com/p/B0rRS_BhKTi/?igshid=10wa2hvuw9tls

[lakhsyatour-blog]

The grandeur and beauty of South India attracts tourist to this place all year round. The backwaters of Kerala and mesmerizing beaches have a rejuvenating effect on people. The swaying palms, cool breeze, shimmering sand and smiling sun at the beaches of South India can add on to the Golden Moments at the place. The internationally famed temples of Tamil Nadu can surely treat the eyes of the tourists. French culture can be experienced in Pondicherry. The enchanting wildlife of Karnataka gives the wild adventurous holidays to the visitors.

09314009015,0924009016

http://lakshyatour.com/South-India-Tour-Packages.html

[crimsonpublishers-medical]

Primary Angle Closure Glaucoma: A Review- Crimson Publishers

Primary Angle Closure Glaucoma: A Review by  Rodiah Rahmawaty Lubis in  Research in Medical & Engineering Sciences

Glaucoma is a leading cause of irreversible blindness worldwide. Primary angle closure glaucoma (PACG), is the second most common form of glaucoma and associated with the closure of the anterior chamber angle. Peripheral anterior synechia (PAS) frequently develop due to an attack of prolonged acute attack or a series subacute attack of angle closure glaucoma. These PAS are usually high and broad and very difficult to find out whether the PAS formed before or during the attack or possibly at both times. Principal management strategy for PACG is about anterior chamber angle by understanding the early stages of appositional angle closure before the PAS. In this review, we describe the current understanding regarding the pathophysiology and treatment of PACG.

For more articles in our journal click on: https://crimsonpublishers.com/rmes/

Read More Crimson Publishers Google Scholar Articles: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=dK3tK7wAAAAJ&citation_for_view=dK3tK7wAAAAJ:0EnyYjriUFMC

[amiriandfriends]

Amiri & Friends #45 - Middle of Nowhere

Artist: @sheastandefer

Adventure 5 of Wrath of the Righteous is pretty merciless with it’s labyrinth-themed movement confusion and restrictions. Even after getting through the two major maze scenarios, minotaurs are still popping up as henchmen, and a bad roll against them can land you...well, in the Middle of Nowhere,  a useless location that is very hard to leave!

[constellations-and-energy]

M.M, Sagittarius Will I be successful in job I'm going to school for?

th e high priestess and pacge of cups

yes, you chose your major for . a raso n and  a subconsiouc part of you neede sd that to be your ca reer. you will be succe sfful because yo will lov ead need to be doing what you re going to e doing 

tip jar

[abosalehuae]

‏‎فروتيس لونج العصائر تقدم لكم افضل انواع الكنافة بحالتها الجديدة . . لذيذ ومنعش Delicious juice fresh فروتيس لونج يقدم لكم الذ انواع العصاير والحلويات فيلذيذ ومنعش Delicious juice fresh فروتيس لونج يقدم لكم الذ انواع العصاير والحلويات في بنياس @fruitslounge 📞025757977 @fruitslounge @fruitslounge 📞025757977 @fruitslounge 📞📞 ——————————————- ————————————— #الشامخة #الشامخ #الشامخه #الشامخة_جنوب #بني_ياس #بنياس #مدينة_خليفةأ #مدينة_خليفةب #مدينة_شخبوط #مدينة_محمد_بن_زايد #ابوظبي #الشامخة_جنوب_أبوظبي #الشامخة_ابوظبي #مكاني_مول #الرحبة #بني_ياس_شرق #بني_ياس_غرب #الغابات _________________________ 🇦🇪🇦🇪🇦🇪🇦🇪🇦🇪🇦🇪🇦🇪 #ra3i_alwifa_uae14_2011102019————————————— ▃▃▃▃▃▃▃▃▃▃▃▃ ••••••••••••••••••••••••••• #قروب_حراج_الامارات_التجاري ••••••••••••••••••••••••• ملاحظة هامة:- (تم نشر الاعلان بناءً على طلب صاحب الاعلان ،، دون تحمل أدنى مسؤولية قانونية تجاه الغير) ‏This AD was published as the request of the owner of the AD without any legal liability to others. —————— ——————— . ‏#HG00013957‎‏ https://www.instagram.com/p/B5kr1S-pAcg/?igshid=1nah9o5poalsx

[skalcon]

Got those new Pathfinder Adventure Card Society scenarios ready. Who else is in for that new core set? #SkalCon #PACG #PACS https://www.facebook.com/pfsskalcon/photos/a.1428524650803423/2393686074287271/?type=3

[healthcare00897]

Acetazolamide Market Entry Strategies, Regulatory Framework, Global Trends, Next-Generation Products Analysis Till 2026

Acetazolamide is carbonic anhydrase inhibitor, used in adjuvant treatment of chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma, epilepsy, edema due to congestive heart failure, drug-induced edema, and acute mountain sickness in climbers. Acetazolamide promotes acclimatization to altitude, increases bicarbonate secretion by the kidneys, induces metabolic acidosis, and stimulates ventilation. Furthermore, according to the BMJ Journal, September 2012, acetazolamide in doses of 250 mg, 500 mg, and 750 mg daily are more effective compared to placebo for preventing acute mountain sickness. In addition, acetazolamide 250 mg daily is the lowest effective dose to prevent acute mountain sickness.

Extended Application of Acetazolamide in Various Treatment Modalities is expected to Drive Market Growth during the Forecast Period

Acetazolamide is used to prevent high altitude illness in most people, which is characterized by headache, nausea, vomiting, and tiredness (often called acute mountain sickness), but may affect the brain or the lungs in different individuals. As per the study published in Cochrane Journal, in June 2017, acetazolamide is an effective and better treatment for the prevention of acute high altitude illness (HAI) in dosages of 250 to 750 mg/day, when compared to a placebo. Acetazolamide prevents acute mountain sickness and has fewer side effects than alternative drugs such as dexamethasone. According to BMJ journal, May 2018, prescribing acetazolamide for travel is an optional service and not included in the general practitioner’s contract in the U.K.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2396

Increasing Prevalence of Glaucoma among Global Population is expected to Aid in Market Growth  

Increasing prevalence of glaucoma and associated risk factors such as high myopia, diabetes, eye surgery or injury, high blood pressure, increased usage of corticosteroids, and family history of glaucoma among the global population are expected to offer conducive future growth for acetazolamide drug manufacturers. As a sustained release capsule of Acetazolamide taken a day, offers a substantial pressure-lowering effect that lasts at least 23 hours. Treatment with acetazolamide helps to reduce eye pressure, which aids in preventing eye damage. Acetazolamide works by blocking the action of an enzyme called carbonic anhydrase thereby, reducing the amount of fluid secreted in the front part of eye, thus lowering eye pressure. For instance, according to the study published in the Journal of Ophthalmology (2014), an estimated 64.3 million people (aged 40-80 years) in 2013, were affected with glaucoma, which would increase to 76.0 million in 2020, and 111.8 million in 2040.

According to the International Agency for the Prevention of Blindness, 2017, glaucoma is the second leading cause of blindness and leading cause of irreversible blindness worldwide. With primary angle closure glaucoma (PACG) being the most common in South-East Asia  while primary open-angle glaucoma (POAG) is mostly found among white Caucasians and individuals of Africa.

Among region, Asia Pacific is expected to be conducive region for the acetazolamide market growth. This is mainly owing to growing healthcare infrastructures, high prevalence of glaucoma, and associated risk factors such as diabetes and high blood pressure cases among the population of the region. For instance, according to American Academy of Ophthalmology (AAO), November 2013, glaucoma is the most common cause of preventable, irreversible blindness worldwide, among which primary open-angle glaucoma (POAG) is responsible for 12.3% of blindness. Furthermore, according to same source, POAG’s prevalence is estimated to be the highest among the people of China, intermediate in Japan, and lower in Europe and India. Therefore, these driving factors are expected to propel growth of acetazolamide market in Asia Pacific.

Key players operating in the acetazolamide market include Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc., Novast Laboratories Ltd., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), Lannett Company, Inc., Strides Shasun Limited, and X-GEN Pharmaceuticals, Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com